Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany-Reference-Cited by-同舟云学术

Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany

Published:2015-11 Issue:6 Volume:6 Page:462-469
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Dall Peter,Lenzen Gertrud,Göhler Thomas,Lerchenmüller Christian,Feisel-Schwickardi Gabriele,Koch Thorsten,Eggert Jochen,Heilmann Volker,Schindler Christof,Wilke Jochen,Tesch Hans,Selbach Johannes,Wohlfarth Tim,Eustermann Heidi,Hinke Axel

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference31 articles.

1. Adjuvant chemotherapy in older women with breast cancer: who and what?;Muss;J Clin Oncol,2014

2. Management of primary and advanced breast cancer in older unfit patients;Aapro;Cancer Treat Rev,2009

3. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology;Wildiers;The Lancet,2007

4. Optimising care of elderly breast cancer patients: a challenging priority;Tipples;Clin Oncol,2009

5. Trastuzumab in small tumours and in elderly women;Albanell;Cancer Treat Rev,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival following adjuvant trastuzumab-based treatment among older patients with HER2-positive early invasive breast cancer: A national population-based cohort study using routine data;European Journal of Cancer;2024-09

2. Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2‐Positive Breast Cancer;International Journal of Breast Cancer;2024-01

4. Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study;The Breast;2022-12

5. Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: a propensity score-adjusted analysis of a prospective cohort study;2022-09-07